Плановые хирургические вмешательства у пациентов, ранее инфицированных COVID-19

Тимербулатов В.М., Валишин Д.А., Тимербулатов Ш.В.

Значительное увеличение количества так называемых «отложенных» пациентов, которым плановые операции переносились на более поздние сроки, после острой фазы ближе к постпандемической фазе COVID-19, создает серьезные проблемы для систем здравоохранения различных стран, вынуждает хирургов предпринимать более активную стратегию для лечения этих пациентов и предотвращения их дальнейшего роста. Известно, что в настоящее время по различным оценкам, в мире накопилось 28 миллионов отложенных операций в пиковый период пандемии COVID-19. Существует также проблема оказания плановой хирургической помощи пациентам, перенесшим бессимптомную форму новой коронавирусной инфекции SARS-CoV-2. До сегодняшнего дня остается недостаточно ясной степень безопасности пациентов, медперсонала, перенесших бессимптомную или симптомную формы COVID-19. Большинство исследователей полагают, что отбор больных для плановых операций и оперативных вмешательств должен основываться на всесторонней, комплексной (в т.ч. лабораторной, инструментальной) оценке состояния пациентов, перенесших COVID-19, и операции должны выполняться с соблюдением противоэпидемических мер, использованием средств индивидуальной защиты медперсоналом и пациентами.

1. Bui N., Coeter M., Schenning KJ, O`Glasser A.Y. Preparing previously COVID-19-positive patients for elective surgery: a framework for preoperative evaluation. Perioperative medicine. 2021; 10: 4. doi: 10.1186/S13741-020-00172-2.

2. Nepogodiev D, Bhangu A. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. 2020. doi: 10.1002/bjs.11746.

3. Prachand VN, Milner R, Angelos P, et al. Medically necessary, time-sensitive procedures: a scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic. J Am Coll Surg, 2020: 231: 281-288.

4. Soreide, Halletj, Matthews JB, et al. Immediateandlong-termimpactofthe COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020. doi: 10.1002/bjs. 11670.

5. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic Transmission, the Achilles Heel of Current Strategies to Control Covid-19. N Engl J Med. 2020; 382: 2158-2160.

6. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med. 2020; 173: 362-367.

7. Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2), Science. 2020; 368: 489-493.

8. Woloshin S, Patel N, Kesselheim AS, False negative tests for SARS-CoV-2 infection — challenges and implications. N Engl J Med. 2020; 283: e38.

9. Watson J, Whiting PF, Brush JE. Interpreting a covid-19 test result. BMJ. 2020; 369: m 1808.

10. Kissler SM, Tedijanto C, Goldstein E, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020: 368: 860.

11. Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCOV-POP): a population-based study. Lancet. 2020; 396: 313-319.

12. Polla’nM, Pe rez-Go‘mezB, Pastor-BarriusoR, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020; 396: 535-544.

13. Soreide K, Yaqub S, Hallet Jetal. A Risk Model of Admitting Patients With Silent SARS-CoV-2 Infection to Surgery and Development of Severe Postoperative Outcomes and Death. Annals of Surgery. 2021; 273(2): 208-216. doi:10.1097/SLA.0000000000004583.

14. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV.2 infection an international cohort study, Lancet. 2020, 396: 27-38.

15. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles heel of current strategies to control Covid-19. N Engl J Med. 2020; 382: 2158-2160.

16. Graham LA, Maldonado YA, Tomkins LS, et al. Asymptomatic SARS-CoV-2 Transmission from Community Contacts in Healthcare Workers. Ann Surg. 2020. doi: 10.1097/SLA.0000000000003968.

17. Holmer H, Bekele A, Hagander L, et al. Evaluating the collection, comparability and findingsof six global surgery indicators. Br J Surg. 2019; 106: e138-150.

18. Weiser TG, Haynes AB, Molina G, et al. Size and distribution of the global volume of surgery in Bull World Health Organ. 2016; 94: 201-209.

19. Omling E, Jarnheimer A, Rose J, et al. Population-based incidence rate of inpatient and outpatient surgical procedures in a high-income country. Br J Surg. 2018; 105: 86-95.

20. Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020. doi: 10.1016/j.eclinm.2020.100331.

21. Pettengill MA, McAdam AJ. Can we test our way out of the COVID-19 pandemic? J Clin Microbiol. 2020. doi: 10.1128/JCM.02225-20.

22. Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012; 380: 1059-1065.

23. Mangalmurti N, Hunter CA. Cytokine Storms: Understanding COVID-19. Immunity. 2020: 53: 19-25.

24. Holter JC, Pischke SE, de Boer E, et al. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc Natl Acad Sci US A. 2020; 117: 25018-25025.

25. Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Global Health. 2020; 8: E1003-E1017.

26. Dowd JB, Andriano L, Brazel DM, et al. Demographic science aids in understanding the spread and fatality rates of COVID-19. Proc Natl Acad Sci US A. 2020; 117: 9696-9698.

27. Nepogodiev D, Bhangu A, Glasbey J, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-COV-2 infection: an international cohort study. Lancet 2020, 396(10243): 27-38.

28. Doglietto F, Vezzoli M, Gheza F, et al. Factors associated with surgical mortality and complications among patients with and without coronavirus disease 2019 (COVID-19) in Italy. JAMA Surg. 2020; 155(8): 691-702.

29. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-62.

30. Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020, 92: 791-6.

31. Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19. J Thromb Haemost. 2020, 18: 1324-9.

32. Tang N, LI D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844-7.

33. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case controlled study. BMC Neurol. 2011; 11(37).

34. Fugl A, Andersen CL. Epstein-Barr virus and its association with disease — a review of relevance to general practice. BMC Fam Pract. 2019; 14(20): 62.

35. Carroll E. Neumann H. Aguero-Rosenfeld ME, et al. Post-COMID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia 2020, 61: e135-9. doi: 10.1111/epi.16683.

36. Chan M. Han SC, Kelly S, Tamimi M, Giglio B, Lewis A. A case series of Guillain-Barré syndrome following COVID-19 infection in New York (published online ahead of print). Neurol Clin Pract. 2020. doi: 10.1212/CPJ. 0000000000000880.

37. Novi G, Rossi T, Pedemonte E, Saitta L. Rolla C, Roccatagliata L, et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5): e797.

38. Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andres E. Immune thrombocytopenic purpura in a patient with COVID-19. N. Engl. J Med. 2020; 382: e43.

39. Galeotti C. Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020; 16: 413-4. doi: 10.1038/ 541584-020-0448-7.

40. Lazarian G, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br. J. Haematol. 2020. doi: 10.1111/bjh.16794.

41. Livhits M. Ko CY, Leonardi MJ, et al. Risk of surgery following recent myocardial infarction. J Vascular Surg. 2011; 253(5): 857-64.

42. Mehdi Z, Birns J, Partridge J, et al. Perioperative management of adult patients with a history of stroke or transient ischaemic attack undergoing elective non-cardiac surgery. Clinical medicine. 2016; 16(6): 535-40.

43. Jørgensen ME, Torp-Pedersen Gislason GH, et al. Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery. JAMA. 2014; 312: 269-77.

44. Canet J, Sanchis J, Briones Z, et al. Recent acute respiratory tract infection in adults is a significant risk factor of postoperative complications. Eur J Anesthesiol. 2008; 25: 72-3.

45. Aquilina AT, Hall WJ, Douglas RG Jr, et al. Airway reactivity in subjects with viral upper respiratory tract infections: the effects of exercise and cold air. Am Rev Respir Dis. 1980; 122(1): 3-10.

46. Bruera E, Kuehn N, Miller M, et al. The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care. 1991; 7: 6-9.

47. Zhao Y, Shang Y, Song W, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. Lancet. 2020; 25: 100463.

48. Mo X, Jian W. Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020, 55(6): 2001217.

49. Xu Z, Shi L Wang Y, et al. Pathological findings of COVID-19 associated with acute syndrome. Lancet Respir Med. 2020; 8: 420-422.

50. Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function functional capacity and quality of life in a cohort of survivors. Thorax. 2005; 60: 401-409.

51. Hui DS Wong KT, Ko FW, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005; 128: 2247-2261.

52. Ngai JC, Ko FW, Ng SS, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010; 15: 543-550.

53. Park WB, Jun KI, Kim G, et al. Correlation between pneumonia severity and pulmonary complications in Middle East respiratory syndrome. J Korean Med Sci. 2018; 33: e169.

54. Zhao Y, Shang Y, Song W, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. 2020. Published Elsevier Ltd. doi: 10/1016/j. eclinm.2020.100463.